Cyclic Therapeutics AB

ABActive

Org 5595087791Research and experimental development on natural sciences and engineering· NACE 7210Est. 2024 · 1 year old1-4 employees

Overview Financials People & ownership Related companies

Cyclic Therapeutics AB is a Swedish AB, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024, the company reported revenue of SEK 541K in its latest annual filing.

Revenue 2025

SEK 541K

EBITDA margin

92.0%

Net profit 2025

SEK 294K

Key ratios

See full ratios →

83.8%

This company

20252025

32.7×

This company

20252025

7.4%

This company

20252025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 541K	—
EBITDA	SEK 498K	—
Net profit	SEK 294K	—
Total assets	SEK 4M	—
Equity	SEK 3,3M	—
Employees	—	—

Frequently asked questions

What is the Org number of Cyclic Therapeutics AB?

Cyclic Therapeutics AB is registered with Bolagsverket / SCB under Org 5595087791.

What is the revenue of Cyclic Therapeutics AB?

Cyclic Therapeutics AB reported revenue of SEK 541K in 2025.

Who is the CEO of Cyclic Therapeutics AB?

Patrick Darren Bryant is the CEO of Cyclic Therapeutics AB, in role since 2026.

Who is the chairman of Cyclic Therapeutics AB?

Thomas Ulf Edvard Helleday chairs the board of Cyclic Therapeutics AB, in role since 2025.

Cyclic Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Frequently asked questions

More on Cyclic Therapeutics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Frequently asked questions

More on Cyclic Therapeutics AB